x
White Chemical Union Logo Gray Chemical Union Logo
About Us
Institutional
Who we are Our History Manufacturing units
All the
Manufacturing Units Brasilia (DF) Brasilia - Bthek (DF) Embu-Guaçu (SP) Guarulhos (SP) Pouso Alegre Graphic Park (MG) Merry Push (MG) Manufacturing Unit Sao Paulo - SP Taboao da Serra (SP) Union Agener Biotechnology Laboratil, Sao Paulo – SP
Factory Visit Investor Relations Corporate Governance Code of Ethics Press Room
Our Structure
Business units
All Business Units Pharmacy By Hospital Agener Outsourcing
Distribution center (MG) Suppliers Research and Development Our Certifications
Products
Pharmacy
Anti-Infectives Cardiovascular System Digestive System Genitourinary System Respiratory System Musculoskeletal System Dermatological Vitamins Several Oral Health Generics See full line
By
Respiratory System Pain Women's Health Central Nervous System Eye Health Skin Care Pediatrics See full line
Hospital
See full line
Agener
Small Animals Large Animals See full line
See full line
Name
Sustainability
Work with us Contact us
Legal information
Privacy Channel - LGPD Code of Ethics Tenders Financial Statements Pay Transparency Report
Contact
FAQ Contact Adverse Events Investor Relations

Logo Bolshoi
Ampara1 Logo

Copyright © 2025 União Química. All rights reserved

return to home

By


It is the business division of União Química dedicated to the medical prescription segment, operating in the areas of ophthalmology, gynecology, orthopedics, central nervous system, dermatology and pediatrics.

1st in market share in ophthalmology in Brazil, its purpose is to provide doctors and patients with a broad and innovative portfolio, allowing greater individualized access to eye health.

• Treatment of chronic and acute diseases, with highlights such as: Lacrifilm®, Drusolol®, Dews®.

• Important international partnership with two relevant products on the market: Hyabak®, Blephagel® and Thealoz Duo®.

Leader in oral hormonal contraceptives in units in Latin America*, the division expanded its portfolio with the acquisition of Bayer's manufacturing plant in São Paulo - SP, integrating nine new products, which made it the leader in the oral hormonal contraceptive market in Latin America, in addition to distributing to more than 30 countries, accelerating the company's internationalization process.*

By

Genom Ophthalmology ranks first among national laboratories in this segment, both in terms of revenue data (IMS) and prescription (Close-up). With a vast portfolio for the treatment of chronic and acute pathologies, the business unit has strong recognition from the medical profession and societies.

  • Division specialized in Medical Prescription products

  • 1st National Laboratory of Ophthalmology**

  • Leadership in Oral Contraceptives in Latin America**

  • Broad portfolio with 70 products and 101 presentations

  • More than 100 thousand visits per month throughout Brazil

Discover Genom products

View Products

Web Stories

Check out the Web Stories from the Genom business unit.
Footnotes

*Source: IQVIA Apr 22

*Source: IQVA - Retail - 2021

Go to top